BIOMAT Database Logo BIOMAT Database Logo

Hyperlipidemia after renal transplantation and its relation to graft and patient survival. 2007

M Ramezani, and B Einollahi, and M Ahmadzad-Asl, and M Nafar, and V Pourfarziani, and A Samadpour, and M Moradi, and M Alghasi, and H Chalian, and F Davoudi
Department of Internal Medicine, Baqyiatallah University of Medical Sciences, Tehran, Iran.

BACKGROUND Hyperlipidemia is a multifactorial event that frequently develops following renal transplantation and may worsen the patient's prognosis. The aim of this study was to evaluate the incidence and concomitant factors for hyperlipidemia. METHODS We studied 687 renal transplant recipients from 1988 to 2004 using a cross-sectional design to determine the frequency of hypercholestrolemia and hypertriglyceridemia before and 1 month to 1 year after renal transplantation, to evaluate its relation to patient and graft prognosis in two medical centers in Iran. Cyclosporine was the constant part of immunosuppressive treatment in all study subjects. RESULTS One and 5-year graft survival times were 94.23% and 81.34%, respectively. The prevalence of hypercholestrolemia after transplantation was 59.9%. Mean (+/- 2 SE) serum cholesterol levels before and after transplantation were 161.15 +/- 3.81 and 213.83 +/- 4.53 mg/dL respectively (P=.000). Triglycerides levels, were 159.99 +/- 13.08 and 196.28 +/- 19.6 mg/dL respectively. There was no significant correlation between cyclosporine dose, graft and patient survivals, and severity of hyperlipidemia (determined by cholesterol and triglyceride levels). CONCLUSIONS Lipid metabolism abnormalities observed in this study were similar to other reports. There was no correlation with patient or graft survival. In addition, there may routes for development of hyperlipidemia other than adverse complications of immunosuppressive drugs.

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D007492 Iran A country bordering the Gulf of Oman, the Persian Gulf, and the Caspian Sea, between Iraq and Pakistan. The capital is Tehran. Islamic Republic of Iran
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006937 Hypercholesterolemia A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population. Hypercholesteremia,Elevated Cholesterol,High Cholesterol Levels,Cholesterol Level, High,Cholesterol Levels, High,Cholesterol, Elevated,Cholesterols, Elevated,Elevated Cholesterols,High Cholesterol Level,Hypercholesteremias,Hypercholesterolemias,Level, High Cholesterol,Levels, High Cholesterol
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015228 Hypertriglyceridemia A condition of elevated levels of TRIGLYCERIDES in the blood. Hypertriglyceridemias
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences
D016019 Survival Analysis A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function. Analysis, Survival,Analyses, Survival,Survival Analyses

Related Publications

M Ramezani, and B Einollahi, and M Ahmadzad-Asl, and M Nafar, and V Pourfarziani, and A Samadpour, and M Moradi, and M Alghasi, and H Chalian, and F Davoudi
Rejection episodes and patient and graft survival after renal transplantation.
June 1975, Clinical nephrology,
M Ramezani, and B Einollahi, and M Ahmadzad-Asl, and M Nafar, and V Pourfarziani, and A Samadpour, and M Moradi, and M Alghasi, and H Chalian, and F Davoudi
Influence of early graft function after renal transplantation and its impact on long-term graft and patient survival.
October 2010, Transplantation proceedings,
M Ramezani, and B Einollahi, and M Ahmadzad-Asl, and M Nafar, and V Pourfarziani, and A Samadpour, and M Moradi, and M Alghasi, and H Chalian, and F Davoudi
Proteinuria after renal transplantation affects not only graft survival but also patient survival.
August 2001, Transplantation,
M Ramezani, and B Einollahi, and M Ahmadzad-Asl, and M Nafar, and V Pourfarziani, and A Samadpour, and M Moradi, and M Alghasi, and H Chalian, and F Davoudi
Determinants of graft survival after renal transplantation.
June 1996, Transplantation,
M Ramezani, and B Einollahi, and M Ahmadzad-Asl, and M Nafar, and V Pourfarziani, and A Samadpour, and M Moradi, and M Alghasi, and H Chalian, and F Davoudi
Renal transplantation and graft survival and its influencing factors.
September 1999, Transplantation proceedings,
M Ramezani, and B Einollahi, and M Ahmadzad-Asl, and M Nafar, and V Pourfarziani, and A Samadpour, and M Moradi, and M Alghasi, and H Chalian, and F Davoudi
Improving graft and patient survival rates in renal transplantation.
January 1979, Proceedings of the Clinical Dialysis and Transplant Forum,
M Ramezani, and B Einollahi, and M Ahmadzad-Asl, and M Nafar, and V Pourfarziani, and A Samadpour, and M Moradi, and M Alghasi, and H Chalian, and F Davoudi
Hyperlipidemia and obesity after renal transplantation.
January 2001, Annals of transplantation,
M Ramezani, and B Einollahi, and M Ahmadzad-Asl, and M Nafar, and V Pourfarziani, and A Samadpour, and M Moradi, and M Alghasi, and H Chalian, and F Davoudi
Graft survival after renal transplantation: agenda for analysis.
October 1983, Kidney international,
M Ramezani, and B Einollahi, and M Ahmadzad-Asl, and M Nafar, and V Pourfarziani, and A Samadpour, and M Moradi, and M Alghasi, and H Chalian, and F Davoudi
Avoiding delays in time to renal transplantation: Pretransplant thyroid malignancy does not affect patient or graft survival after renal transplantation.
January 2022, Surgery,
M Ramezani, and B Einollahi, and M Ahmadzad-Asl, and M Nafar, and V Pourfarziani, and A Samadpour, and M Moradi, and M Alghasi, and H Chalian, and F Davoudi
Early graft function and patient survival following cadaveric renal transplantation.
February 1999, Kidney international,
Copied contents to your clipboard!